Ignite Creation Date:
2024-05-11 @ 8:30 AM
Last Modification Date:
2024-10-26 @ 3:29 PM
Study NCT ID:
NCT06406829
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-05-14
First Post:
2024-05-06
Brief Title:
Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomy
Sponsor:
Beijing Tiantan Hospital
Organization:
Beijing Tiantan Hospital
Study Overview
Official Title:
Perioperative Multimodal Analgesia Protocol for Supratentorial Craniotomya 2 2 Factorial Randomized Clinical Trial
Status:
NOT_YET_RECRUITING
Status Verified Date:
2024-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Supratentorial craniotomy is one of the most common neurosurgical procedures with severe perioperative pain Inadequate perioperative pain relief has been associated with increased blood pressure and intracranial pressure favoring bleeding and cerebral cerebral hypoperfusion The ideal analgesia for neurosurgery requires complete pain relief eliminates the side effects of opioid drugs and no influence for neurological function Previous studies have proposed a multimodal analgesic strategy combining analgesics and local anaesthesia it is expected to achieve the above benefits
Detailed Description:
The trial has been designed to analyze the efficacy of local analgesic techniques and dexmedetomidine in the treatment of postoperative acute pain in craniotomy This randomized clinical trial aims to enroll 2000 patients which will be randomized to one of 4 groups
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None